APLIF

Appili Therapeutics Inc. APLIF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode APLIF AGNPF RNUGF ADXS IBOGF NMLSF RGBP VGLS AAGH IBXXF
6M 37.04 % 4.51 % 0.00 % -66.67 % -68.90 % 67.81 % -80.95 % 0.00 % -66.67 % 25.00 %
YTD -40.08 % 15.12 % 0.00 % 48.52 % -54.46 % 176.33 % -85.02 % 0.00 % 0.00 % -71.43 %
1Y -43.08 % 21.25 % 0.00 % 48.52 % -54.46 % 132.07 % -83.64 % 0.00 % -50.00 % -71.43 %
3Y -43.30 % -87.38 % -98.90 % -96.29 % -65.54 % -88.74 % -99.72 % 9 900.00 % 25.00 % -98.42 %
5Y -98.44 % -98.65 % -99.89 % -99.87 % -93.26 % -95.26 % -97.82 % -97.96 % -96.02 % -99.77 %
10Y -98.89 % -99.69 % -99.96 % -100.00 % -93.26 % -91.51 % -99.99 % -99.57 % -75.00 % -99.58 %
From the beginning -98.89 % -99.69 % -100.00 % -100.00 % -93.26 % -99.80 % -99.99 % -100.00 % -99.78 % -99.58 %

Dividend